drugset / Trial / NCT01249261
Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover
RandomizedParallel-groupOpen-labelTreatment
Summary
The effects of stopping long-term (7 years) and short term (2 years) risedronate therapy on BMD (bone mineral density) and BTMs (bone turnover markers) will be summarized.
Timeline
- Start
- 2001-10
- Primary completion
- 2003-05
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risedronate | Small molecule | 5 mg | — |